We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company's products ar... ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company's products are normally applied topically using a patent-pending delivery system technology. Presently, the products are used within the OTC drug market, i.e. non-prescription. However, the Company believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies. Show more
June 1, 2021 -- InvestorsHub NewsWire -- via BullishInvestor.com/WSGF The stock price direction for the day for WSGF is UP. The stock is experiencing a downtrend as of late...
March 16, 2021 -- InvestorsHub NewsWire -- via SeekingAlpha -- Alternet Systems, Inc. (ALYI) By: Manshi Mamtora, CFA2 Comments Alternet...
Halitron, Inc. (HAON) Buying Back Shares, Following the Berkshire Hathaway Model "Building Shreholder Value through Strategic Acquisitions" Miami, FL -- InvestorsHub NewsWire...
Halitron, Inc. (HAON) Buying Back Shares, Following the Berkshire Hathaway Model "Building Shreholder Value through Strategic Acquisitions" Miami, FL -- InvestorsHub NewsWire...
ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA PR Newswire LOS ANGELES, Oct. 30, 2014 LOS ANGELES, Oct. 30, 2014 /PRNewswire/ --Β ViaDerma, Inc...
ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 ViaDerma, Inc.'s Groundbreaking Transdermal Delivery Method Designed to Improve Commercial Value of Pharmaceuticals PR...
ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group Collaboration will help promote ViaDerma's innovative technology and expand the domestic and international demand for its...
GUANGDONG PROVINCE, China, Feb. 25, 2011 (GLOBE NEWSWIRE) -- Decor Products International, Inc. (Pink Sheets:DCRD), a leading designer and manufacturer of decor paper products headquartered in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0005 | -6.25 | 0.008 | 0.0086 | 0.007 | 2736015 | 0.0079042 | CS |
4 | -0.0019 | -20.2127659574 | 0.0094 | 0.0116 | 0.007 | 1828536 | 0.00867508 | CS |
12 | 0.002 | 36.3636363636 | 0.0055 | 0.014 | 0.0045 | 2510965 | 0.00845974 | CS |
26 | 0.002 | 36.3636363636 | 0.0055 | 0.014 | 0.0025 | 2082304 | 0.00695343 | CS |
52 | -0.006 | -44.4444444444 | 0.0135 | 0.015 | 0.0025 | 1738409 | 0.00817899 | CS |
156 | -0.0019 | -20.2127659574 | 0.0094 | 0.225 | 0.002 | 2183287 | 0.01091098 | CS |
260 | 0.0063 | 525 | 0.0012 | 0.225 | 0.0008 | 6895683 | 0.01931047 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions